Simplex Trading
CATX icon

Simplex Trading’s Perspective Therapeutics CATX Stock Holding History

Simplex Trading’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Sell
3,500
-51,700
-94% -$195K ﹤0.01% 7548
2026
Q1 		$230K Buy
+55,200
New +$233K ﹤0.01% 4137
2025
Q4 		– Sell
-7,900
Closed -$27K – 8657
2025
Q3 		$27K Buy
7,900
+4,300
+119% +$15.7K ﹤0.01% 7057
2025
Q2 		$12K Sell
3,600
-17,100
-83% -$45.1K ﹤0.01% 7157
2025
Q1 		$44K Buy
20,700
+500
+2% +$1.5K ﹤0.01% 5892
2024
Q4 		$64K Buy
+20,200
New +$165K ﹤0.01% 5610

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Simplex Trading's CATX Position: Q2 2026 in Review

Simplex Trading reduced its Perspective Therapeutics (CATX) stake by 20% in Q2 2026, selling an estimated $32.3K and leaving 33,940 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #5362.

Simplex Trading first reported a position in CATX in Q1 2026 and has held it in 2 quarters since. The position peaked at $177K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Simplex Trading held 33,940 shares of Perspective Therapeutics worth $116K as of Q2 2026.
  • Simplex Trading sold 8,546 Perspective Therapeutics shares in Q2 2026, an estimated $32.3K.
  • Perspective Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5362 holding.
  • Simplex Trading first reported a position in Perspective Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Simplex Trading's Perspective Therapeutics position peaked at $177K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.